Cello Health PLC (LON:CLL)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $122.00. Cello Health shares last traded at $121.00, with a volume of 71,090 shares.
Separately, FinnCap reiterated a “corporate” rating on shares of Cello Health in a research report on Wednesday, March 27th.
The company has a debt-to-equity ratio of 4.70, a current ratio of 1.28 and a quick ratio of 1.23. The firm has a market cap of $126.13 million and a PE ratio of 19.67. The business’s 50-day moving average is GBX 129.47.
In related news, insider Mark Bentley sold 129,800 shares of the firm’s stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of GBX 127 ($1.66), for a total value of £164,846 ($215,400.50).
About Cello Health (LON:CLL)
Cello Health plc, together with its subsidiaries, provides marketing services in the United Kingdom, Rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients.
Featured Story: How to identify percentage decliners
Receive News & Ratings for Cello Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cello Health and related companies with MarketBeat.com's FREE daily email newsletter.